Literature DB >> 10827002

Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.

L Hansen1, B Hartmann, T Bisgaard, H Mineo, P N Jørgensen, J J Holst.   

Abstract

Suspecting that paracrine inhibition might influence neuronal regulation of the endocrine L cells, we studied the role of somatostatin (SS) in the regulation of the secretion of the proglucagon-derived hormones glucagon-like peptide-1 and -2 (GLP-1 and GLP-2). This was examined using the isolated perfused porcine ileum stimulated with acetylcholine (ACh, 10(-6) M), neuromedin C (NC, 10(-8) M), and electrical nerve stimulation (NS) with or without alpha-adrenergic blockade (phentolamine 10(-5) M), and perfusion with a high-affinity monoclonal antibody against SS. ACh and NC significantly increased GLP secretion, whereas NS had little effect. SS immunoneutralization increased GLP secretion eight- to ninefold but had little influence on the GLP responses to ACh, NC, and NS. Basal SS secretion (mainly SS28) was unaffected by NS alone. Phentolamine + NS and NC abstract strongly stimulated release mainly of SS14, whereas ACh had little effect. Infused intravascularly, SS14 weakly and SS28 strongly inhibited GLP secretion. We conclude that GLP secretion is tonically inhibited by a local release of SS28 from epithelial paracrine cells, whereas SS14, supposedly derived from enteric neurons, only weakly influences GLP secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827002     DOI: 10.1152/ajpendo.2000.278.6.E1010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  33 in total

1.  A Strong Stomach for Somatostatin.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2015-11       Impact factor: 4.736

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.

Authors:  J J Holst; C F Deacon
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

4.  Contributions of fat and protein to the incretin effect of a mixed meal.

Authors:  Guillaume Carrel; Léonie Egli; Christel Tran; Philippe Schneiter; Vittorio Giusti; David D'Alessio; Luc Tappy
Journal:  Am J Clin Nutr       Date:  2011-08-17       Impact factor: 7.045

5.  Does GLP-1 suppress its own basal secretion?

Authors:  Dariush Elahi; Dennis A Ruff; Olga D Carlson; Graydon S Meneilly; Joel F Habener; Josephine M Egan
Journal:  Endocr Res       Date:  2015-07-17       Impact factor: 1.720

6.  The distribution and chemical coding of enteroendocrine cells in Trypanosoma cruzi-infected individuals with chagasic megacolon.

Authors:  Patrícia Rocha Martins; Josiane Fakhry; Adriana Jacaúna de Oliveira; Thayse Batista Moreira; Linda J Fothergill; Enio Chaves de Oliveira; Débora d'Ávila Reis; John B Furness
Journal:  Histochem Cell Biol       Date:  2021-01-06       Impact factor: 4.304

Review 7.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10

8.  GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.

Authors:  Lærke S Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria B N Gabe; Flemming Dela; Tina Vilsbøll; Jens J Holst; Mette M Rosenkilde; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-25       Impact factor: 10.122

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  HOMA-IR in acromegaly: a systematic review and meta-analysis.

Authors:  Betina Biagetti; Anna Aulinas; Anna Casteras; Santiago Pérez-Hoyos; Rafael Simó
Journal:  Pituitary       Date:  2020-10-21       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.